Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 40

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 40
---
 NewGenIvf’s net revenue effectively and affect the value of your investment.                               |
| ● | Substantially all of NewGenIvf’s assets and operations are located in Thailand, Cambodia and Kyrgyzstan and they are subject to economic, legal and regulatory uncertainties in such countries. |

| ● | Failure to comply with the terms of future financing arrangements could result in default, which could have an adverse effect on NewGenIvf’s cash flow and liquidity.                                                                               |
| ● | NewGenIvf requires a significant amount of capital to fund its operations and growth. If NewGenIvf cannot obtain sufficient capital on acceptable terms, its business, financial condition, and prospects may be materially and adversely affected. |

| ● | The defects in certain leased property interests and failure to register certain lease agreements may materially and adversely affect NewGenIvf’s business, financial condition, results of operations, and prospects. |
| ● | NewGenIvf currently has no insurance coverage for its operations.                                                                                                                                                      |
| ● | NewGenIvf may not be successful in adapting to technological developments, which may affect its business and results of operations.                                                                                    |

<div align='center'>20</div>

| ● | If its computer systems, or those of its providers, specialty pharmacies or other downstream vendors lag, fail or suffer security breaches, NewGenIvf may incur a material disruption of its services, which could materially impact its business and the results of operations. |
| ● | We may not be able to comply with the filing deadlines for reports that we file pursuant to the Exchange Act, and our failure to timely file such reports may have material adverse consequences on our business.                                                                |
| ● | If we are unable to continue to meet the listing requirements of Nasdaq, our Class A Ordinary Shares will be delisted.                                                                                                                                                           |

Risks Related to NewGenIvf’s Relationships with Third Parties

| ● | NewGenIvf’s business depends on its ability to maintain its network of high-quality fertility specialists and other healthcare providers. If NewGenIvf is unable to do so, its future growth would be limited and its business, financial condition and results of operations would be harmed.                                                                                                                |
| ● | The medical facilities and professionals in NewGenIvf’s network could become the subject of litigation, allegations and other claims, and NewGenIvf is not insured against these liabilities.                                                                                                                                                                                                                 |
| ● | The assisted reproductive medical facilities in NewGenIvf’s network have limited control over the quality of the